IRIS
CRIPPA, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.007
NA - Nord America 958
AS - Asia 151
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
OC - Oceania 1
Totale 2.131
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 955
SE - Svezia 687
IT - Italia 157
CN - Cina 76
IE - Irlanda 49
FI - Finlandia 47
IN - India 27
HK - Hong Kong 26
DE - Germania 25
GB - Regno Unito 25
JP - Giappone 9
EG - Egitto 7
FR - Francia 5
EU - Europa 4
IR - Iran 4
NL - Olanda 4
RS - Serbia 4
CL - Cile 3
ID - Indonesia 3
SG - Singapore 3
ES - Italia 2
MX - Messico 2
BE - Belgio 1
CA - Canada 1
CZ - Repubblica Ceca 1
KR - Corea 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TR - Turchia 1
Totale 2.131
Salva come PNG Salva come JPEG
Città #
Lawrence 190
Princeton 190
Ashburn 154
New York 106
Shanghai 76
Milan 55
Helsinki 46
Dublin 44
Pune 27
Hong Kong 26
London 23
Los Angeles 17
Rome 17
Washington 17
Seattle 12
Al Mansurah 6
Carlsbad 5
Alessandria 4
Campodolcino 4
Galliate 4
Santa Clara 4
Borås 3
Hanover 3
Heidelberg 3
Jakarta 3
Naples 3
Portland 3
Salt Lake City 3
Santiago 3
Strongoli 3
Tokyo 3
Barcelona 2
Bari 2
Bassano del Grappa 2
Berlin 2
Brescia 2
Cambridge 2
Camponogara 2
Castel Madama 2
Cordenons 2
Cormano 2
Modena 2
Mountain View 2
Naaldwijk 2
Portogruaro 2
Puebla City 2
Redwood City 2
Rivoli 2
Rozzano 2
Salem 2
San Giuseppe Vesuviano 2
Svilajnac 2
Aalter 1
Ancona 1
Asheville 1
Bergamo 1
Bollate 1
Brighton 1
Castelseprio 1
Chiba 1
Council Bluffs 1
Elmendorf 1
Frankfurt am Main 1
Fremont 1
Harrow 1
Kocaeli 1
Lappeenranta 1
Lower Hutt 1
Minamiedo 1
Münster 1
Orzinuovi 1
Quezon City 1
Redmond 1
Rimini 1
Rockville 1
Seoul 1
Shinchiba 1
Singapore 1
Stanford 1
Tehran 1
Trumbull 1
Verona 1
Yokohama 1
Zanjan 1
Totale 1.131
Salva come PNG Salva come JPEG
Nome #
Evolving pancreatic cancer treatment: From diagnosis to healthcare management 31
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 29
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 28
THE VALUE OF (18)FLUOR-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (18FDG-PET/CT) IN RESECTABLE PANCREATIC CANCER: A PROSPECTIVE STUDY 23
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 21
Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway 20
A multimodality test to guide the management of patients with a pancreatic cyst 20
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 20
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy 20
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 19
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 19
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 18
Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study 18
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 17
Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma 17
Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign? 17
The impact of minimally invasive surgery on hospital readmissions, emergency department visits and functional recovery after distal pancreatectomy 17
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 15
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 15
Consensus guidelines on severe acute pancreatitis 15
Implications of increased serum amylase after pancreaticoduodenectomy: toward a better definition of clinically relevant postoperative acute pancreatitis 15
Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts 15
Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies 15
Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients. Preliminary report 15
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 15
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 14
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 14
A preoperative score to predict early death after pancreatic cancer resection 14
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 14
Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence? 14
Before sentinel bleeding: early prediction of postpancreatectomy hemorrhage (PPH) with a CT-based scoring system 14
Prediction of early distant recurrence in upfront resectable pancreatic adenocarcinoma: A multidisciplinary, machine learning-based approach 14
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 13
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 13
The impact of preoperative anemia on pancreatic resection outcomes 13
Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease. 13
D evelopment of ductal adenocarcinoma during follow-up of branch-duct IPMNs 13
Early postoperative prediction of clinically relevant pancreatic fistula after pancreaticoduodenectomy: usefulness of C-reactive protein 13
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 13
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 13
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 13
Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis 13
An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program 13
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study 13
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 13
Duodeno-jejunal or gastro-enteric leakage after pancreatic resection: a case–control study 13
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 13
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 12
Mesoangioblasts at 20: From the embryonic aorta to the patient bed 12
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 12
Limited impact of discretization/interpolation parameters on the predictive power of CT radiomic features in a surgical cohort of pancreatic cancer patients 12
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis 12
Endoscopic ultrasound-guided gastrojejunostomy does not prevent pancreaticoduodenectomy after long-term symptom-free neoadjuvant treatment 12
Justifying vein resection with pancreato-duodenectomy 12
Middle pancreatectomy: indications, short- and long-term operative outcomes. 12
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 12
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 12
Minimally Invasive Versus Open Treatment for Benign Sporadic Insulinoma Comparison of Short-Term and Long-Term Outcomes 12
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals 12
Management of ampullary neoplasms: A tailored approach between endoscopy and surgery 12
Pancreatic cystic neoplasms: What is the most cost-effective follow-up strategy? 12
Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer 12
Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein 11
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 11
Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer 11
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 11
Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment 11
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 11
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 11
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 11
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 11
Enhanced recovery pathways in pancreatic surgery: state of the art 11
Rectal indomethacin to prevent post-ERCP pancreatitis 11
Extent of surgery and implications of transection margin status after resection of IPMNs. 11
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival 11
Early Versus Late Drain Removal After Standard Pancreatic Resections Results of a Prospective Randomized Trial 11
A grading system can predict clinical and economic outcomes of pancreatic fistula after pancreaticoduodenectomy: results in 755 consecutive patients. 11
A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients 11
Pancreatic cystic tumours: when to resect, when to observe 11
Acute pancreatitis at the beginning of the 21st century: the state of the art. 11
Ki-67 prognostic and therapeutic decision driven marker for pancreatic neuroendocrine neoplasms (PNENs): A systematic review 11
Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors 11
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 11
MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer 11
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 11
Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy 10
Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial 10
Risk factors for the occurrence of ampullary tumors: A case-control study 10
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 10
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 10
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 10
Management of clinically relevant postoperative pancreatic fistula-related fluid collections after distal pancreatectomy 10
SILS cholecystectomy, early experience of a single institution: pilot study of 21 cases. 10
Poorly differentiated resectable pancreatic cancer: Is upfront resection worthwhile? 10
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 10
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts--a shape shifting outlook into an increasingly recognized disease. 10
Gallbladder carcinoid: a case report 10
Correction to: Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature? (Clinical and Translational Gastroenterology, (2018), 9, 6, (158), 10.1038/s41424-018-0026-3) 10
SYSTEMATIC REVIEW AND META-ANALYSIS OF STUDIES COMPARING METAL OR PLASTIC STENTS FOR PREOPERATIVE BILIARY DRAINAGE IN RESECTABLE PANCREATIC CANCER 10
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 10
Totale 1.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/202020 9 0 0 0 0 0 10 0 0 0 1 0
2020/202146 0 0 1 0 6 30 6 1 2 0 0 0
2021/2022110 0 0 6 50 7 3 7 5 8 12 4 8
2022/20231.291 449 269 96 6 12 168 87 97 58 7 13 29
2023/2024838 33 41 110 134 107 218 22 112 21 38 2 0
Totale 2.330